<SEC-DOCUMENT>0001213900-22-044311.txt : 20220803
<SEC-HEADER>0001213900-22-044311.hdr.sgml : 20220803
<ACCEPTANCE-DATETIME>20220803093427
ACCESSION NUMBER:		0001213900-22-044311
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220802
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220803
DATE AS OF CHANGE:		20220803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEUROONE MEDICAL TECHNOLOGIES Corp
		CENTRAL INDEX KEY:			0001500198
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				270863354
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40439
		FILM NUMBER:		221131180

	BUSINESS ADDRESS:	
		STREET 1:		7599 ANAGRAM DR
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
		BUSINESS PHONE:		(952) 426-1383

	MAIL ADDRESS:	
		STREET 1:		7599 ANAGRAM DR
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Original Source Entertainment, Inc.
		DATE OF NAME CHANGE:	20100830
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea163726-8k_neuroone.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:NMTC="http://n1mtc.com/20220802">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_NMTC_n1mtc.com_20220802 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20220802_20220802 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001500198 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityCentralIndexKey">0001500198</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nmtc-20220802.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-08-02to2022-08-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001500198</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-02</xbrli:startDate>
        <xbrli:endDate>2022-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: normal 18pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20220802__20220802_zRhSLBJAg5y2"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90E_edei--DocumentPeriodEndDate_c20220802__20220802_zSLd7OdTgLf7"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 2, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt; font-variant: small-caps"><b><span id="xdx_90C_edei--EntityRegistrantName_c20220802__20220802_zqsQ0FlYbIti"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityRegistrantName">NeuroOne
Medical Technologies Corporation</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of Registrant as Specified in Its
Charter)</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20220802__20220802_zekNWhOUfvab"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_902_edei--EntityFileNumber_c20220802__20220802_zuGBcROfBwoc"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityFileNumber">001-40439</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20220802__20220802_zMJEjGko1nla"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityTaxIdentificationNumber">27-0863354</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><b>(State or other jurisdiction<br />
of incorporation)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>(Commission File Number)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>(IRS Employer</b></span><br />
<span style="font-size: 10pt"><b>Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20220802__20220802_z5mtfSqXy0E2"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityAddressAddressLine1">7599 Anagram Dr.</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20220802__20220802_zqX5Ctz7wl5"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityAddressCityOrTown">Eden Prairie</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20220802__20220802_zcFsLQT59DOl"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Minnesota</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20220802__20220802_z7sp5VY1IKP"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:EntityAddressPostalZipCode">55344</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices, including
Zip Code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s Telephone Number, Including
Area Code: <span id="xdx_909_edei--CityAreaCode_c20220802__20220802_zI0p6yscsjR9"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:CityAreaCode">952</ix:nonNumeric></span>-<span id="xdx_905_edei--LocalPhoneNumber_c20220802__20220802_zW4pv8bKLkS"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:LocalPhoneNumber">426-1383</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_edei--WrittenCommunications_c20220802__20220802_zyNuobfKWVIk"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--SolicitingMaterial_c20220802__20220802_zMKo8ymfY7Hj"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20220802__20220802_z9vErTYNdmYe"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20220802__20220802_zjIDa89S22ub"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading<br />
Symbol(s)</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20220802__20220802_zNjnEMfWfiK4"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_909_edei--TradingSymbol_c20220802__20220802_zhcaEM8w0dP6"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" name="dei:TradingSymbol">NMTC</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>The <span id="xdx_906_edei--SecurityExchangeName_c20220802__20220802_zFiLVqa3RF66"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20220802__20220802_zZ7ivZfIesZb"><ix:nonNumeric contextRef="From2022-08-02to2022-08-02" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01.&#160;&#160;Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Third Amendment to Exclusive Development
and Distribution Agreement with Zimmer, Inc.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 2, 2022, NeuroOne Medical
Technologies Corporation (the &#8220;<b><i>Company</i></b>&#8221;) entered into a Third Amendment to Exclusive Development and
Distribution Agreement (the <b><i>&#8220;Third Amendment&#8221;</i></b>) with Zimmer, Inc., a Delaware corporation
(<b><i>&#8220;Zimmer&#8221;</i></b>). Pursuant to the terms and conditions of the Third Amendment, Zimmer agreed to make a $3,500,000
payment (the <b><i>&#8220;Payment&#8221;</i></b>) to the Company within 10 business days of the execution of the Third Amendment.
The Payment to be made by Zimmer to the Company is non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Third Amendment extended the
term of the license granted to Zimmer under the Strip/Grid Distribution License (as defined in the Exclusive Development and Distribution
Agreement dated July 20, 2020 (the <b><i>&#8220;Distribution Agreement&#8221;</i></b>), and the SEEG Distribution License through the term
of the Distribution Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Third Amendment
is not complete and is qualified in its entirety by reference to the Third Amendment, which is attached hereto as Exhibit 10.1 and incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Private Placement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 2, 2022, in connection with the Third
Amendment, the Company issued Zimmer a Warrant to Purchase Common Stock (the <b><i>&#8220;Warrant&#8221;</i></b>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant will be exercisable for up to an aggregate
of 350,000 shares of the Company&#8217;s common stock, par value $0.001 (the <b><i>&#8220;Common Stock&#8221;</i></b>). The Warrant will
have an exercise price of $3.00 per share, will be exercisable commencing six months from the issuance date (the <b><i>&#8220;Initial
Exercise Date&#8221;</i></b>), and will expire on August 2, 2027 (the <b><i>&#8220;Initial Exercise Date&#8221;</i></b>). Subject to limited
exceptions, Zimmer will not have the right to exercise any portion of the Warrant if Zimmer, together with its affiliates, would beneficially
own in excess of 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise (the <b><i>&#8220;Beneficial
Ownership Limitation&#8221;</i></b>); provided, however, that upon prior notice to the Company, the holder may increase or decrease the
Beneficial Ownership Limitation, provided further that in no event shall the Beneficial Ownership Limitation exceed 19.99% and any increase
in the beneficial ownership limitation will not be effective until 61 days following notice to the Company. After the Initial Exercise
Date and prior to expiration, subject to the terms and conditions set forth in the Warrant, Zimmer may exercise the Warrant for the shares
of the Common Stock issuable pursuant to the Warrant by providing notice to the Company and paying the exercise price per share for each
share so exercised or by utilizing the &#8220;cashless exercise&#8221; feature contained in the Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Warrant is not
complete and is qualified in its entirety by reference to the Warrant, which is attached hereto as Exhibit 4.1 and incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 3.02.&#160;&#160;Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described more fully in Item 1.01 above, which
description is hereby incorporated by reference into this Item 3.02, the Company issued the Warrant to Zimmer, who is an accredited investor,
in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;<b><i>Securities
Act</i></b>&#8221;). The Company will rely on this exemption from registration based in part on representations made by Zimmer. Neither
the Warrant nor the shares of the Common Stock issuable upon the exercise of the Warrant been registered under the Securities Act or applicable
state securities laws and may not be offered or sold in the United States absent registration under the Securities Act or an exemption
from such registration requirements. Neither this Current Report on Form 8-K nor any exhibit attached hereto shall constitute an offer
to sell or the solicitation of an offer to buy the Warrant, shares of the Common Stock or any other securities of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 3, 2022, NeuroOne Medical Technologies
Corporation issued a press release announcing entry into the Third Amendment. A copy of this press release is filed herewith as Exhibit
99.1 to this Current Report and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-size: 10pt"><b>&#160; Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea163726ex4-1_neuroone.htm">Warrant to Purchase Common Stock</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.1*</span></td>
    <td>&#160;</td>
    <td><a href="ea163726ex10-1_neuroone.htm"><span style="font-size: 10pt">Third Amendment to Exclusive Distribution and Development Agreement</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><a href="ea163726ex99-1_neuroone.htm"><span style="font-size: 10pt"><span style="text-decoration: none">Press Release, dated August 3, 2022</span></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded with Inline XBRL document). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 60%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 40%"><span style="font-size: 10pt; font-variant: small-caps"><b>NeuroOne Medical Technologies Corporation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 60%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.2pt; text-indent: -7.2pt; border-left-width: 0cm; border-left-color: Black">Date:
    August 3, 2022</p></td>
    <td style="width: 4%"><span style="font-size: 10pt">By: </span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 36%"><span style="font-size: 10pt">/s/ David Rosa</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt">David Rosa</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt"><i>&#160;</i></span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt"><i>President and Chief Executive Officer</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwjAQRE/QOyz5Fk2DivTToiJWkSLib7BbCbbZskmrHslbGlvEZWFZZt6MECOxobWpkOGyzDM4Yd1U2iPkWCKjvWJwpNtdAuHmeDPOs7a+f39gSoHBwMzG8VQHobd2xmGRgFxMpJooBTJO5ByOexF99ZRsaQq03ugKtC3gyNSwQa/5NSSc9JMs1a++6ozsDNkE4rEc5DcoGSs4UKcfxHcHWZaKaNRPJDZMbfOtaZ2nGlYV1qHLDeh/ow8WJklG -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea163726ex4-1_neuroone.htm
<DESCRIPTION>WARRANT TO PURCHASE COMMON STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NEITHER THIS SECURITY NOR
THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE <B><I>&ldquo;SECURITIES
ACT&rdquo;</I></B>), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE
STATE SECURITIES OR BLUE SKY LAWS, PURSUANT TO REGISTRATION OR QUALIFICATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY
MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE COMPANY MAY REQUIRE AN OPINION OF
COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY TO THE EFFECT THAT ANY PROPOSED TRANSFER IS IN COMPLIANCE WITH THE
SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES OR BLUE SKY LAWS. THIS SECURITY IS SUBJECT TO THE TRANSFER RESTRICTIONS SET FORTH HEREIN
AS AMENDED FROM TIME TO TIME, COPIES OF WHICH ARE AVAILABLE WITH THE SECRETARY OF THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>NeuroOne
Medical Technologies Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Warrant
to Purchase Common Stoc</B>k</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Number of Shares: 350,000 (subject to adjustment)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 50%">Warrant No. 2022 COM-1</TD>
  <TD STYLE="text-align: right; width: 50%">Original Issue Date:
August 2, 2022</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>NeuroOne
Medical Technologies Corporation</B></FONT>, a Delaware corporation (the <B><I>&ldquo;Company&rdquo;</I></B>), hereby certifies that,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>Zimmer,
Inc.</B></FONT>, a Delaware corporation or its registered assigns (the <B><I>&ldquo;Holder&rdquo;</I></B>), is entitled, subject to the
terms set forth below, to purchase from the Company up to a total of 350,000 shares of the Common Stock, $0.001 par value per share (the
<B><I>&ldquo;Common Stock&rdquo;</I></B>), of the Company (each such share, a <B><I>&ldquo;Warrant Share&rdquo;</I></B> and all such shares,
the <B><I>&ldquo;Warrant Shares&rdquo;</I></B>) at an exercise price per share equal to $3.00 per share (as adjusted from time to time
as provided in <U>Section 9</U> herein, the <B><I>&ldquo;Exercise Price&rdquo;</I></B>) upon surrender of this Warrant to Purchase Common
Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this <B><I>&ldquo;Warrant&rdquo;</I></B>)
at any time and from time to time on or after the six (6) month anniversary of the Original Issue Date (the <B><I>&ldquo;Initial Exercise
Date&rdquo;</I></B>) and through and including the earlier of 5:30 P.M., New York City time, on August 2, 2027 or the expiration
or termination of this Warrant as set forth herein (the <B><I>&ldquo;Expiration Date&rdquo;</I></B>), subject to the following terms and
conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Definitions</B></FONT>.
For purposes of this Warrant, the following terms shall have the following meanings:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(a)</B></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Affiliate</I></B>&rdquo; means any Person that,
directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as
such terms are used in and construed under Rule 405 under the Securities Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(b)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Closing Sale Price&rdquo;</I></B> means, for
any security as of any date, the last trade price for such security on the Principal Trading Market for such security, as reported by
Bloomberg L.P., or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the last trade
price, then the last trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg L.P., or if the security
is not listed for trading on a Trading Market on the relevant date, the last quoted bid price for the security in the over-the-counter
market on the relevant date as reported by OTC Markets Group Inc. (or a similar organization or agency succeeding to its functions of
reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases,
the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.
If the Company and the Holder are unable to agree upon the fair market value of such security, then the fair market value shall be determined
by an independent qualified appraiser selected mutually by the Company and the Holder and paid for by the Company. The independent qualified
appraiser&rsquo;s determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(c)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Commission&rdquo;</I></B> and/or <B><I>&ldquo;SEC&rdquo;
</I></B>means the United States Securities and Exchange Commission.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(d)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Marketable Securities&rdquo;</I></B> means securities
meeting all of the following requirements: (i) the issuer thereof is then subject to the reporting requirements of Section 13 or Section
15(d) of the Securities Exchange Act of 1934, as amended (the <B><I>&ldquo;Exchange Act&rdquo;</I></B>), and is then current in its filing
of all required reports and other information under the Securities Act and the Exchange Act; (ii) the class and series of shares or other
security of the issuer that would be received by Holder in connection with the Fundamental Transaction (as defined below) were Holder
to exercise this Warrant on or prior to the closing thereof is then traded or quoted on a nationally recognized securities exchange,
inter-dealer quotation system or over-the-counter market, and (iii) following the closing of such Fundamental Transaction, the Holder
would not be restricted from publicly re-selling all of the issuer&rsquo;s shares and/or other securities that would be received by the
Holder in such Fundamental Transaction were the Holder to exercise or convert this Warrant in full on or prior to the closing of such
Fundamental Transaction, except to the extent that any such restriction (x) arises solely under applicable securities laws, rules or
regulations, and (y) does not extend beyond six (6) months from the closing of such Fundamental Transaction.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(e)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Person&rdquo;</I></B> means an individual or
corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any kind.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(f)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Principal Trading Market&rdquo; </I></B>means
the Trading Market, if any, on which the Common Stock is primarily listed on and quoted for trading.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(g)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Trading Day&rdquo;</I></B> means a day on which
the Principal Trading Market is open for trading. If the Common Stock is not listed or admitted for trading, &ldquo;Trading Day&rdquo;
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking
institutions in New York City are authorized or required by law or other governmental action to close.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(h)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Trading Market&rdquo;</I></B> means any of the
following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American,
the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors
to any of the foregoing).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(i)</B></TD><TD STYLE="text-align: justify"><B><I>&ldquo;Transfer Agent&rdquo;</I></B> means Action Stock
Transfer Corporation, the Company&rsquo;s transfer agent and registrar for the Common Stock, and any successor appointed in such capacity.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Warrant Register</B></FONT>.
The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that purpose (the <B><I>&ldquo;Warrant
Register&rdquo;</I></B>), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee
to which this Warrant is assigned hereunder) from time to time. The Company may deem and treat the registered Holder of this Warrant
as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent
actual notice to the contrary.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Registration of
Transfers</B></FONT>. Subject to compliance with all applicable securities laws, the conditions herein and such reasonable requirements
as the Company may require, the Company shall, or will cause the Transfer Agent to, register the transfer of all or any portion of this
Warrant in the Warrant Register, upon surrender of this Warrant, and payment for all applicable transfer taxes (if any). Upon any such
registration or transfer, a new warrant to purchase Common Stock in substantially the form of this Warrant (any such new warrant, a <B><I>&ldquo;New
Warrant&rdquo;</I></B>) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing
the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New
Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of
the New Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause the Transfer Agent to, prepare, issue
and deliver at the Company&rsquo;s own expense any New Warrant under this <U>Section 3</U>. Until due presentment for registration of
transfer, the Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall not be affected
by any notice to the contrary. This Warrant and the Warrant Shares are and may continue to be subject to resale restrictions and hold
periods, and the Holder (and any transferee) should consult its legal advisor in respect of the same. If, at the time of the surrender
of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant
to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible
for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company
may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, provide to
the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which
opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred
portion of this Warrant under the Securities Act. The Holder, by the acceptance hereof, represents and warrants that it is acquiring
this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not
with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities law, except pursuant to sales registered or exempted under the Securities Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Exercise and Duration
of Warrant</B></FONT>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(a)</B></TD><TD STYLE="text-align: justify">All or any part of this Warrant shall be exercisable by the
registered Holder in any manner permitted by this Warrant at any time and from time to time on or after the Initial Exercise Date and
through and including the Expiration Date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(b)</B></TD><TD STYLE="text-align: justify">The Holder may exercise this Warrant by delivering to the
Company an exercise notice, in the form attached as <FONT STYLE="font-variant: small-caps"><U>Schedule 1</U></FONT> attached hereto (the
<B><I>&ldquo;Exercise Notice&rdquo;</I></B>), completed and duly signed. Within one (1) Trading Day following the date of delivery of
the Exercise Notice, the Holder shall make payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is
being exercised (which may take the form of a &ldquo;cashless exercise&rdquo; if so indicated in the Exercise Notice pursuant to <U>Section
10</U> below). The date on which such Exercise Notice is delivered to the Company (as determined in accordance with the notice provisions
hereof) is an <B><I>&ldquo;Exercise Date&rdquo;</I></B>; provided, that if the Exercise Price is not delivered on or before one (1) Trading
Day following the date of delivery of the Exercise Notice, the Exercise Date shall be deemed to be one (1) Trading Day following the
date of that the Exercise Price is delivered to the Company. No ink-original Notice of Exercise shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. The Holder shall not be required to deliver
the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect
as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant
Shares, if any. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of
this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Delivery of Warrant
Shares</B></FONT>. Upon exercise of this Warrant, the Company shall promptly (but in no event later than two (2) Trading Days after the
Exercise Date) credit such aggregate number of shares of the Common Stock to which the Holder is entitled pursuant to such exercise in
book entry form with the Transfer Agent.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>6.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Charges, Taxes and
Expenses</B></FONT>. Issuance and delivery of certificates for shares of the Common Stock upon exercise of this Warrant shall be made
without charge to the Holder for any issue or transfer tax, fees of the Transfer Agent or other incidental tax or expense (excluding
any applicable stamp duties) in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company;
<I>provided, however</I>, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved
in the registration of any certificates for Warrant Shares or this Warrant in a name other than that of the Holder or an Affiliate thereof.
The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving
Warrant Shares upon exercise hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>7.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Replacement of Warrant</B></FONT>.
If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for
and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and reasonable indemnity
and surety bond, if requested by the Company which shall not be required if the Holder provides an affidavit of loss and self-indemnity.
Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay
such other reasonable third-party costs as the Company may prescribe (for the avoidance of doubt, the Holder shall not be required to
pay any costs related to legal counsel for the Company). If a New Warrant is requested as a result of a mutilation of this Warrant, then
the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company&rsquo;s obligation to issue the
New Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>8.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Reservation of Warrant
Shares</B></FONT>. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available out
of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are then issuable and deliverable
upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the
Holder (taking into account the adjustments and restrictions of <U>Section 9</U>). The Company covenants that all of the Warrant Shares
so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof,
be duly and validly authorized, issued and fully paid and non-assessable. The Company will take all such action as may be reasonably
necessary to assure that such shares of the Common Stock may be issued as provided herein without violation of any applicable law or
regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Stock may be listed.
The Company further covenants that it will not, without the prior written consent of the Holder, take any actions to increase the par
value of the Common Stock at any time while this Warrant is outstanding.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>9.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Certain Adjustments</B></FONT>.
The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as
set forth in this <U>Section 9</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(a)</B></TD><TD STYLE="text-align: justify"><B>Stock Dividends and Splits</B>. If the Company, at any
time while this Warrant is outstanding, (i) pays a stock dividend on shares of the Common Stock or otherwise makes a distribution on
any class of capital stock issued and outstanding on the Original Issue Date and in accordance with the terms of such stock on the Original
Issue Date that is payable in shares of the Common Stock, (ii) subdivides its outstanding shares of the Common Stock into a larger number
of shares of the Common Stock, (iii) combines its outstanding shares of the Common Stock into a smaller number of shares of the Common
Stock or (iv) issues by reclassification of shares of capital stock any additional shares of the Common Stock of the Company, then in
each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the number of shares of the Common
Stock outstanding immediately before such event and the denominator of which shall be the number of shares of the Common Stock outstanding
immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution, provided, however, that if such
record date shall have been fixed and such dividend is not fully paid on the date fixed therefor, the Exercise Price shall be recomputed
accordingly as of the close of business on such record date and thereafter the Exercise Price shall be adjusted pursuant to this paragraph
as of the time of actual payment of such dividends. Any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective
immediately after the effective date of such subdivision or combination.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(b)</B></TD><TD STYLE="text-align: justify"><B>Pro Rata Distributions</B>. If the Company, at any time
while this Warrant is outstanding, distributes to all holders of shares of the Common Stock for no consideration (i) evidences of its
indebtedness, (ii) any security (other than a distribution of shares of the Common Stock covered by the preceding paragraph), (iii) rights
or warrants to subscribe for or purchase any security, or (iv) cash or any other asset (in each case, a <B><I>&ldquo;Distribution&rdquo;</I></B>),
other than a reclassification as to which <U>Section 9(c)</U> applies, then in each such case, the Holder shall be entitled to participate
in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of
the Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the ownership limitation set forth in <U>Section 11(a)</U> hereof) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of the Common Stock are to be determined
for the participation in such Distribution (provided, however, to the extent that the Holder&rsquo;s right to participate in any such
Distribution would result in the Holder exceeding the ownership limitation set forth in <U>Section 11(a)</U> hereof, then the Holder
shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of the Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until the earlier of (i) such time, if ever, as the delivery to such Holder of such portion would not result in the Holder
exceeding the ownership limitation set forth in <U>Section 11(a)</U> hereof and (ii) such time as the Holder has exercised this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(c)</B></TD><TD STYLE="text-align: justify"><B>Fundamental Transactions</B>. If, at any time while this
Warrant is outstanding (i) the Company effects any merger or consolidation of the Company with or into another Person, in which the Company
is not the surviving entity and in which the stockholders of the Company immediately prior to such merger or consolidation do not own,
directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii)
the Company effects any sale to another Person of all or substantially all of its assets in one transaction or a series of related transactions,
(iii) pursuant to any tender offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares
representing more than 50% of the voting power of the capital stock of the Company and the Company or such other Person, as applicable,
accepts such tender for payment, (iv) the Company consummates a stock purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires
more than the 50% of the voting power of the capital stock of the Company (not including any shares of the Common Stock held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination and excluding shares acquired upon conversion of any currently outstanding convertible
securities in accordance with the terms thereof as in effect on the date hereof) or (v) the Company effects any reclassification of the
Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other
securities, cash or property (other than as a result of a subdivision or combination of shares of the Common Stock covered by <U>Section
9(a)</U> above) (in any such case, a <B><I>&ldquo;Fundamental Transaction&rdquo;</I></B>), then following such Fundamental Transaction
the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as
it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such
Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard
to any limitations on exercise contained herein (the <B><I>&ldquo;Alternate Consideration&rdquo;</I></B>). The Company shall not effect
any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another
Person unless (i) the Alternate Consideration is solely cash and the Company provides for the simultaneous &ldquo;cashless exercise&rdquo;
of this Warrant pursuant to <U>Section 10</U> below or (ii) prior to or simultaneously with the consummation thereof, any successor to
the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver
to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and
the other obligations under this Warrant. The provisions of this paragraph (c) shall similarly apply to subsequent transactions analogous
of a Fundamental Transaction type. Notwithstanding the foregoing, in the event of a Fundamental Transaction where the consideration payable
to holders of the Common Stock consists solely of cash, solely of Marketable Securities or a combination of cash and Marketable Securities,
then this Warrant shall automatically be deemed to be exercised in full in a &ldquo;cashless exercise&rdquo; pursuant to <U>Section 10
</U>below effective immediately prior to and contingent upon the consummation of such Fundamental Transaction.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(d)</B></TD><TD STYLE="text-align: justify"><B>Number of Warrant Shares</B>. Simultaneously with any
adjustment to the Exercise Price pursuant to <U>Section 9</U> (including any adjustment to the Exercise Price that would have been effected
but for the final sentence in this <U>paragraph (d)</U>), the number of Warrant Shares that may be purchased upon exercise of this Warrant
shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the
increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such
adjustment. Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock then
in effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(e)</B></TD><TD STYLE="text-align: justify"><B>Calculations</B>. All calculations under this <U>Section
9</U> shall be made to the nearest one-tenth of one cent or the nearest share, as applicable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(f)</B></TD><TD STYLE="text-align: justify"><B>Notice of Adjustments</B>. Upon the occurrence of each
adjustment pursuant to this <U>Section 9</U>, the Company at its expense will, at the written request of the Holder, promptly compute
such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment,
including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon
exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts
upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder
and to the Transfer Agent.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(g)</B></TD><TD STYLE="text-align: justify"><B>Notice of Corporate Events</B>. If, while this Warrant
is outstanding, the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its
Common Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the
Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for
any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then,
except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver
to the Holder a notice of such transaction at least ten (10) days prior to the applicable record or effective date on which a Person
would need to hold Common Stock in order to participate in or vote with respect to such transaction; provided, however, that the failure
to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice.
In addition, if while this Warrant is outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits
stockholder approval for any Fundamental Transaction contemplated by <U>Section 9(c)</U>, other than a Fundamental Transaction under
clause (iii) of <U>Section 9(c)</U>, then the Company shall deliver to the Holder a notice of such Fundamental Transaction at least ten
(10) days prior to the date such Fundamental Transaction is consummated. Holder agrees to maintain any information disclosed pursuant
to this <U>Section 9(g)</U> in confidence until such information is publicly available, and shall comply with applicable law with respect
to trading in the Company&rsquo;s securities following receipt any such information.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>10.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Payment of Exercise
Price</B></FONT>. This Warrant shall be exercised for cash; provided, however, that if at the time of exercise hereof there is no effective
registration statement registering, or the prospectus contained therein is not available for, the issuance of the Warrant Shares, and
there is also no effective registration statement registering the resale by the Holder of the Warrant Shares, then the Holder may, in
its sole discretion, satisfy its obligation to pay the Exercise Price through a &ldquo;cashless exercise&rdquo;, in which event the Company
shall issue to the Holder the number of the Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities
Act, as determined as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">X = Y [(A-B)/A]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;X&rdquo; equals the number of the
Warrant Shares to be issued to the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;Y&rdquo; equals the total number
of the Warrant Shares with respect to which this Warrant is then being exercised;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;A&rdquo; equals the Closing Sale
Price per share of the Common Stock as of the Trading Day immediately preceding the Exercise Date if the Exercise Notice is delivered
prior to market close on the Exercise Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;B&rdquo; equals the Exercise Price
per Warrant Share then in effect on the Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of Rule 144 promulgated under the
Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a &ldquo;cashless exercise&rdquo; transaction
shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced,
on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper
at the time of such exercise). Except as set forth in <U>Section 12</U> (payment of cash in lieu of fractional shares), in no event will
the exercise of this Warrant be settled in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>11.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Limitations on Exercise</B></FONT>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(a)</B></TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary contained herein,
the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise this Warrant for a number
of the Warrant Shares in excess of that number of the Warrant Shares which, upon giving effect or immediately prior to such exercise,
would cause (i) the aggregate number of shares of the Common Stock beneficially owned by the Holder, its Affiliates and any other Persons
whose beneficial ownership of the Common Stock would be aggregated with the Holder&rsquo;s for purposes of Section 13(d) of the Exchange
Act to exceed 4.99% (the <B><I>&ldquo;Maximum Percentage&rdquo;</I></B>) of the total number of issued and outstanding shares of the
Common Stock of the Company following such exercise, or (ii) the combined voting power of the securities of the Company beneficially
owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of the Common Stock would be aggregated with
the Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act to exceed 4.99% of the combined voting power of all of the securities
of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding shares
of the Common Stock, the Holder may rely on the number of outstanding shares of the Common Stock as reflected in (x) the Company&rsquo;s
most recent Form 10-Q or Form 10-K, as the case may be, filed with the Commission prior to the date hereof, (y) a more recent public
announcement by the Company or (z) any other notice by the Company or the Transfer Agent setting forth the number of shares of the Common
Stock outstanding. Upon the written request of the Holder, the Company shall within three (3) Trading Days confirm in writing or by electronic
mail to the Holder the number of shares of the Common Stock then outstanding. In any case, the number of outstanding shares of the Common
Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by
the Holder since the date as of which such number of outstanding shares of the Common Stock was reported. By written notice to the Company,
the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 19.99%
specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is
delivered to the Company. For purposes of this <U>Section 11(a)</U>, the aggregate number of shares of the Common Stock or voting securities
beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of the Common Stock would be aggregated
with the Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act shall include the shares of the Common Stock issuable upon
the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of the Common
Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder
and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that
do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire
at any time shares of the Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares
of the Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially
owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of the Common Stock would be aggregated with
the Holder&rsquo;s for purposes of Section 13(d) of the Exchange Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(b)</B></TD><TD STYLE="text-align: justify">This <U>Section 11</U> shall not restrict the number of shares
of the Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration
that such Holder may receive in the event of a Fundamental Transaction as contemplated in <U>Section 9(c)</U> of this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>12.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>No Fractional Shares</B></FONT>.
No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares that would
otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company shall
pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>13.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Notices</B></FONT>.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in
writing and shall be deemed given and effective, whether or not received by the recipient party, on the earliest of (i) the time of transmission,
if such notice or communication is delivered via confirmed e-mail prior to 5:30 P.M., New York City time, on a Trading Day, (ii) the
next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed e-mail on a day that is not
a Trading Day or later than 5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if
sent by nationally recognized overnight courier service specifying next business day delivery, or (iv) upon actual receipt by the Person
to whom such notice is required to be given, if by hand delivery. The addresses and e-mail addresses for such communications shall be:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">NeuroOne Medical Technologies
Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Attention: CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">7559 Anagram Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Eden Prairie, Minnesota 55344</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Email: DaveR@N1MTC.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to the Holder, notice shall be given to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Zimmer, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">c/o General Manager</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Zimmer Biomet CMF and Thoracic
LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1520 Tradeport Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Jacksonville, Florida 32218</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Email: brian.hatcher@zimmerbiomet.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Or, in each of the above instances, notice shall
be given to such other address or e-mail address as the recipient party has specified by written notice given to each other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>14.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Warrant Agent</B></FONT>.
The Company shall initially serve as warrant agent under this Warrant. Upon ten (10) days&rsquo; notice to the Holder, the Company may
appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting
from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any
new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent
under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant
agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&rsquo;s last address as shown on the Warrant Register.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>15.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B>Miscellaneous</B></FONT>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(a)</B></TD><TD STYLE="text-align: justify"><B>No Rights as a Stockholder</B>. The Holder, solely in
such Person&rsquo;s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder
of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder,
solely in such Person&rsquo;s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right
to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior
to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(b)</B></TD><TD STYLE="text-align: justify"><B>Authorized Shares</B>. Except and to the extent as waived
or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate or articles
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary
to enable the Company to perform its obligations under this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(c)</B></TD><TD STYLE="text-align: justify"><B>Successors and Assigns</B>. Subject to compliance with
applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written
consent of the Holder, except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to
the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in
this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause
of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and
assigns.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(d)</B></TD><TD STYLE="text-align: justify"><B>Amendment and Waiver</B>. Except as otherwise provided
herein, the provisions of the Warrant may be amended and the Company may take any action herein prohibited, or omit to perform any act
herein required to be performed by it, only if the Company has obtained the written consent of the Holder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(e)</B></TD><TD STYLE="text-align: justify"><B>Acceptance</B>. Receipt of this Warrant by the Holder
shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(f)</B></TD><TD STYLE="text-align: justify"><B>Governing Law; Jurisdiction</B>. ALL QUESTIONS CONCERNING
THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER
HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF
MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED
HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT
TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT. EACH
OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH
SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY)
TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF
PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED
BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(g)</B></TD><TD STYLE="text-align: justify"><B>Headings</B>. The headings herein are for convenience
only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>(h)</B></TD><TD STYLE="text-align: justify"><B>Severability</B>. In case any one or more of the provisions
of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions
of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree
upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Warrant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Signatures
on the Following Page</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>In
Witness Whereof</B></FONT>, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>NeuroOne Medical Technologies<BR>
 Corporation</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave Rosa</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and President</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCHEDULE 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM OF EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[To be executed by the Holder to purchase shares
of the Common Stock under the Warrant]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) The
undersigned is the Holder of Warrant No. ___ (the <B><I>&ldquo;Warrant&rdquo;</I></B>) issued by NeuroOne Medical Technologies Corporation,
a Delaware corporation (the <B><I>&ldquo;Company&rdquo;</I></B>). Capitalized terms used herein and not otherwise defined herein have
the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) The undersigned hereby
exercises its right to purchase <U> </U> Warrant Shares pursuant to the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) The
Holder intends that payment of the Exercise Price shall be made as (check one):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744; Cash Exercise</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744; &ldquo;Cashless Exercise&rdquo;
under <U>Section 10</U> of the Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) If
the Holder has elected a Cash Exercise, the Holder shall pay the sum of $ in immediately available funds to the Company in accordance
with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) Pursuant
to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the terms of the Warrant.
The Warrant Shares shall be delivered in book entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(6) By
its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced
hereby the Holder will not beneficially own in excess of the number of shares of the Common Stock (as determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 11(a) of the Warrant to which this notice
relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name of Holder: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">SSN/EIN: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature must conform in all respects to name
of Holder as specified on the face of the Warrant)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ea163726ex10-1_neuroone.htm
<DESCRIPTION>THIRD AMENDMENT TO EXCLUSIVE DISTRIBUTION AND DEVELOPMENT AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">Exhibit 10.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>THIRD AMENDMENT TO</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXCLUSIVE DEVELOPMENT
AND DISTRIBUTION AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS THIRD AMENDMENT TO EXCLUSIVE
DEVELOPMENT AND DISTRIBUTION AGREEMENT (this &ldquo;<U>Amendment</U>&rdquo;) is entered into as of August 2, 2022 (the &ldquo;<U>Effective
Date</U>&rdquo;), by and between Zimmer, Inc., a Delaware corporation (&ldquo;<U>Zimmer</U>&rdquo;), and NeuroOne Medical Technologies
Corporation, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;). Zimmer and the Company are referred to individually as a &ldquo;<U>Party</U>&rdquo;
and together as the &ldquo;<U>Parties</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, on or about July 20,
2020, the Parties entered into a written Exclusive Development and Distribution Agreement, as subsequently amended (collectively the &ldquo;<U>Agreement</U>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parties have agreed
to amend the Agreement consistent with the terms herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the mutual
covenants and agreements contained in the Agreement and this Amendment, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Zimmer shall pay Company the amount of three million, five hundred thousand dollars ($3,500,000) within
ten (10) business days of the execution of this Amendment (the &ldquo;Payment&rdquo;).&nbsp; &nbsp;The Payment is comprised of the following:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">a)</TD><TD STYLE="text-align: justify">One million, five hundred thousand dollars ($1,500,000) for the SEEG Exclusivity Maintenance Fee; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">b)</TD><TD STYLE="text-align: justify">Two million dollars ($2,000,000) for satisfaction of each of the Events set forth in Sections 6.1(c)(i)-(iv)
even though the satisfaction was after the deadlines identified in the tables set forth in Section 6.1(c).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">Upon receipt by the Company of the Payment,
the Company acknowledges and agrees that: (a) Zimmer has satisfied its payment obligations associated with exclusivity right pursuant
to the Agreement and that the Company shall not be entitled to any additional payments from Zimmer for exclusivity, including pursuant
to Section 6.1 of the Agreement or any other related provision(s); and (b) Zimmer&rsquo;s distribution rights as set forth in the terms
and conditions of the Agreement shall be exclusive pursuant to the terms and conditions of Section 6.1(b) of the Agreement in exchange
for the Payment. Zimmer acknowledges and agrees that pursuant to Section 6.1(e) of the Agreement, the Payment is non-refundable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">In consideration of the above, Paragraph 10.2 of the Agreement shall be superseded and replaced with the
following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">10.2 <U>Term of Exclusivity.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">The license rights granted to Zimmer
under the Strip/Grid Distribution License and SEEG Distribution License shall be exclusive from the Effective Date until the end of the
Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise defined herein,
capitalized terms shall have the meanings set forth in the Agreement. The terms of this Amendment amend and modify the Agreement as if
fully set forth in the Agreement. If there is any conflict between the terms, conditions and obligations of this Amendment and the Agreement,
this Amendment&rsquo;s terms, conditions and obligations shall control. All other provisions of the Agreement not specifically modified
by this Amendment are preserved. This Amendment may be executed in counterparts (including via facsimile or .pdf), each of which shall
be deemed an original, and all of which together shall constitute one and the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF, </B>the
Parties hereto have executed this Amendment as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>N</B></FONT><B><FONT STYLE="font-variant: small-caps">euro</FONT><FONT STYLE="text-transform: uppercase">o</FONT><FONT STYLE="font-variant: small-caps">ne Medical</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps"><B>Technologies Corporation</B></FONT></P>

</TD>
  <TD>&nbsp;</TD>
  <TD COLSPAN="2" STYLE="text-align: left; vertical-align: bottom"><B>Zimmer, Inc.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD>
  <TD STYLE="width: 20%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">By:</P></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Dave Rosa&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">By:</P></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Chad F. Phipps</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Name:</P></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">Dave Rosa&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Name:&nbsp;</P></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">Chad F. Phipps</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Title:</P></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">CEO and President</TD>
  <TD>&nbsp;</TD>
  <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Title:</P></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">SVP, General Counsel &amp; Secretary</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea163726ex99-1_neuroone.htm
<DESCRIPTION>PRESS RELEASE, DATED AUGUST 3, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NeuroOne<SUP>&reg;</SUP> Announces $3.5 Million
Accelerated Milestone Payment from Zimmer Biomet for Evo<FONT STYLE="text-decoration: none"><SUP>&reg; </SUP>sEEG Electrode</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><I>Amendment provides
Zimmer Biomet with 350,000 warrants with exercise price of $3.00 per share</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">EDEN PRAIRIE, Minn., August 3, 2022&nbsp;(PR
Newswire) --&nbsp;NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (&ldquo;NeuroOne&rdquo; or the &ldquo;Company&rdquo;), a medical
technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced
that the Company entered into an amendment to its Exclusive Development and Distribution Agreement with Zimmer Biomet, Inc. (&ldquo;Zimmer&rdquo;)
that will provide the Company with a $3.5 million accelerated payment within 10 business days which relates to certain milestone payments.
In addition, Zimmer Biomet will receive a Warrant to purchase 350,000 shares of the Company&rsquo;s common stock, with an exercise price
of $3.00 per share.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dave Rosa, Chief Executive Officer of NeuroOne,
states, &ldquo;I want to thank Zimmer for all their support to date and their confidence in our business, technology and future endeavors.
This agreement accomplishes multiple objectives for NeuroOne, most importantly by providing additional capital to our balance sheet in
the short-term without the need for a highly dilutive financing, and further reinforcing our ongoing partnership with Zimmer.&rdquo;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Brian Hatcher, President of the Trauma, CMFT,
Foot and Ankle Division of Zimmer said, &ldquo;We look forward to continuing the relationship with NeuroOne as we advance our mission
to alleviate pain and improve the quality of life for people around the world.&rdquo; Under the Exclusive Development and Distribution
Agreement signed by both parties in July 2020, Zimmer Biomet has exclusive global distribution rights to distribute the Company&rsquo;s
Cortical and sEEG diagnostic electrode technology.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About NeuroOne</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">NeuroOne Medical Technologies Corporation
is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation
and ablation solutions for patients suffering from epilepsy, Parkinson&rsquo;s disease, dystonia, essential tremors, chronic pain due to failed
back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. For more information,
visit&nbsp;<B>https://www.n1mtc.com</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">This press release may include forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Except for statements of historical fact, any information contained in this presentation may be a forward&ndash;looking
statement that reflects NeuroOne&rsquo;s current views about future events and are subject to known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information
expressed or implied by these forward-looking statements. In some cases, you can identify forward&ndash;looking statements by the words
or phrases &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;objective,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo;
&ldquo;project,&rdquo; &ldquo;potential,&rdquo; &ldquo;target,&rdquo; &ldquo;seek,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;continue, &ldquo;focused
on,&rdquo; &ldquo;committed to&rdquo; and &ldquo;ongoing,&rdquo; or the negative of these terms, or other comparable terminology intended to
identify statements about the future. Forward&ndash;looking statements may include statements regarding the future of NeuroOne&rsquo;s
partnership with Zimmer, NeuroOne&rsquo;s receipt of the $3.5 million payment, and NeuroOne&rsquo;s need for short-term financing. Although
NeuroOne believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on
a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual
future results may be materially different from what we expect due to factors largely outside our control, including risks that the partnership
with Zimmer Biomet may not facilitate the commercialization or market acceptance of our technology; risks that our sEEG electrodes may
not be ready for commercialization in a timely manner or at all, whether due to supply chain disruptions, labor shortages, the impact
of COVID-19 or otherwise; risks that our technology will not perform as expected based on results of our pre-clinical and clinical trials;
risks related to uncertainties associated with the Company&rsquo;s capital requirements to achieve its business objectives and ability to raise
additional funds; the risk that the COVID-19 pandemic will continue to adversely impact our business; the risk that we may not be able
to secure or retain coverage or adequate reimbursement for our technology; uncertainties inherent in the development process of our technology;
risks related to changes in regulatory requirements or decisions of regulatory authorities; that we may not have accurately estimated
the size and growth potential of the markets for our technology; risks relate to clinical trial patient enrollment and the results of
clinical trials; that we may be unable to protect our intellectual property rights; and other risks, uncertainties and assumptions, including
those described under the heading &ldquo;Risk Factors&rdquo; in our filings with the Securities and Exchange Commission. These forward&ndash;looking
statements speak only as of the date of this press release and NeuroOne undertakes no obligation to revise or update any forward&ndash;looking
statements for any reason, even if new information becomes available in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;Caution: Federal law restricts this
device to sale by or on the order of a physician&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">800-631-4030</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@n1mtc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">44750872</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>nmtc-20220802.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaWLuaPtyJ1xyYkxuG9/fXk6TyMjuqQRiihpdMZm4ToN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:NMTC="http://n1mtc.com/20220802" elementFormDefault="qualified" targetNamespace="http://n1mtc.com/20220802">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://n1mtc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nmtc-20220802_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nmtc-20220802_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>nmtc-20220802_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>nmtc-20220802_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://n1mtc.com/role/Cover" xlink:href="nmtc-20220802.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://n1mtc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140200205800368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  02,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NeuroOne
Medical Technologies Corporation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001500198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-0863354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7599 Anagram Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Eden Prairie<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">426-1383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NMTC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>ea163726-8k_neuroone_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nmtc-20220802.xsd" xlink:type="simple"/>
    <context id="From2022-08-02to2022-08-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001500198</identifier>
        </entity>
        <period>
            <startDate>2022-08-02</startDate>
            <endDate>2022-08-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-08-02to2022-08-02">0001500198</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-08-02to2022-08-02">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-08-02to2022-08-02">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-08-02to2022-08-02">2022-08-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-08-02to2022-08-02">NeuroOne Medical Technologies Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-08-02to2022-08-02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-08-02to2022-08-02">001-40439</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-08-02to2022-08-02">27-0863354</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-08-02to2022-08-02">7599 Anagram Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-08-02to2022-08-02">Eden Prairie</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-08-02to2022-08-02">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-08-02to2022-08-02">55344</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-08-02to2022-08-02">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-08-02to2022-08-02">426-1383</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-08-02to2022-08-02">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-08-02to2022-08-02">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-08-02to2022-08-02">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-08-02to2022-08-02">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-08-02to2022-08-02">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-08-02to2022-08-02">NMTC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-08-02to2022-08-02">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-08-02to2022-08-02">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ 3$P#50=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" !,3 -5"1F\@>X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " !,3 -5F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $Q, U51
M:K%P6 0  ),0   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " !,3 -5GZ ;\+$"  #B#   #0
M    @ &;#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $Q, U67BKL<P
M !,"   +              "  7</  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M $Q, U6JQ"(6,P$  "("   /              "  6 0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " !,3 -5)!Z;HJT   #X 0  &@
M@ ' $0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !,
M3 -599!YDAD!  #/ P  $P              @ &E$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  #O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea163726-8k_neuroone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://n1mtc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea163726-8k_neuroone.htm">ea163726-8k_neuroone.htm</File>
    <File>ea163726ex10-1_neuroone.htm</File>
    <File>ea163726ex4-1_neuroone.htm</File>
    <File>ea163726ex99-1_neuroone.htm</File>
    <File>nmtc-20220802.xsd</File>
    <File>nmtc-20220802_lab.xml</File>
    <File>nmtc-20220802_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea163726-8k_neuroone.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea163726-8k_neuroone.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nmtc-20220802_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nmtc-20220802_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nmtc-20220802.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "NMTC",
   "nsuri": "http://n1mtc.com/20220802",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea163726-8k_neuroone.htm",
      "contextRef": "From2022-08-02to2022-08-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://n1mtc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea163726-8k_neuroone.htm",
      "contextRef": "From2022-08-02to2022-08-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://n1mtc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001213900-22-044311-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-044311-xbrl.zip
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MRZ*Y:>8'93Z4DO6*PPODL#]WC_:2,Y.1,Y4_?0?W*_$>:3Z ]M]\++0 6#D
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M26,AQ/,H9$T&Z4(/-,!8@^ARC7LPYDQ>H@M/;N 6/VP(.*-HWLCD2$F_=O@
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M7',H!QB2GV8<SHX:.=E?+SA\L!L"/=!W0%M$$L9R<$<:N18Z;C@?GO>C<T.
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MMF$YY[W^>;,CF\33Z35QE_CHW\^;)^UC&$Q_ 8=Z>D8?<*VMXU[W=%>U.[\
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MXE0FY[W<MAHEZYP Q66"%\YU(6760WI+=-@PTZ?!3,.O9*9L#:[FGJQ!H5Z
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MT<)DV4\T-KOJV\9W\R1\-W=(1FXZ^BK2J6I9!^4<QA.BICJVLBS?1DRH69S
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M2YXDR2ZUKYR>UJRY\=PIQ5/LNFL^/A#7)AFUV@QSC;JB3$M@5!,C:P+R=C(
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M-3L%ZP_<7 %X'@>( 3T.7&. )FQH.L)^36.$I=B2V]2H!,B&4XA8Q38$(64
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MM\CTD"06)W!8$@7OB"2V/,5E\<4VN%ZD+;1OT"U/^LZ@I1R( RD*R]$I+/\
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M90']5DTT.]-Y]6YD3$S>[+7%1%Z%^Z]=RMKN4+O;:Y]TCY8Z:97P<X)*<OI
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M"=Z7[\B@?!&CT I;*'BOB'A2V=S$JWLE8TK=](G>G&V @ B8 ;1)$./3%Z'
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M975R;V]N92YH=&U02P$"% ,4    " !-3 -5FD[:VT<_  #Q5@$ &@
M        @ &1(   96$Q-C,W,C9E>#0M,5]N975R;V]N92YH=&U02P$"% ,4
M    " !-3 -5AG0N%D@,  #B*0  &P              @ $08   96$Q-C,W
M,C9E>#DY+3%?;F5U<F]O;F4N:'1M4$L! A0#%     @ 34P#57Y7'WLG P
MH@L  !$              ( !D6P  &YM=&,M,C R,C X,#(N>'-D4$L! A0#
M%     @ 34P#57*4Y-[^"@  @(8  !4              ( !YV\  &YM=&,M
M,C R,C X,#)?;&%B+GAM;%!+ 0(4 Q0    ( $U, U7C:?RZ4P<  ,]7   5
M              "  1A[  !N;71C+3(P,C(P.# R7W!R92YX;6Q02P4&
/  < !P#E 0  GH(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
